Veterinary Medicines

DOLPAC MEDIUM DOGS TABLETS

Not authorised
  • Oxantel pamoate
  • Praziquantel
  • Pyrantel embonate
Download as PDF

Product identification

Medicine name:
DOLPAC 200,28+49,94+50MG/TAB ΔΙΣΚΙΟ
DOLPAC MEDIUM DOGS TABLETS
Active substance:
  • Oxantel pamoate
  • Praziquantel
  • Pyrantel embonate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Oxantel pamoate
    559.00
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    50.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    144.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol S.A.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 46693/28-06-2012/K-0171202
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0183/002